Security record · archived quarter
PSNL
Personalis, Inc. · Healthcare · Medical - Diagnostics & Research
8Tracked holders
—Δ holders
8.68MShares held
$10.16MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 68 | +6 | 44.71M | $598.60M | +11 | −5 |
| Q1 2026 | 65 | +1 | 39.38M | $250.81M | +9 | −8 |
| Q4 2025 | 64 | +1 | 35.38M | $281.65M | +2 | −1 |
| Q3 2025 | 13 | 0 | 21.61M | $140.91M | — | — |
| Q2 2025 | 10 | -1 | 19.31M | $126.70M | — | −1 |
| Q1 2025 | 8 | -2 | 10.69M | $37.54M | — | −2 |
| Q4 2024 | 10 | 0 | 10.13M | $58.56M | — | — |
| Q3 2024 | 9 | +1 | 11.64M | $62.64M | +2 | −1 |
| Q2 2024 | 8 | — | 8.68M | $10.16M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 6.36M | — | $7.44M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 1.03M | — | $1.20M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 415.40K | — | $486,140 | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 415.40K | — | $486,140 | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 355.24K | — | $415,632 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 355.24K | — | $415,632 | 0.0% | n/c | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 195.35K | — | $228,562 | 0.0% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 195.35K | — | $228,562 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 120.86K | — | $141,411 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 109.85K | — | $128,528 | 0.0% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 95.00K | — | $112,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 140 holders, 84.04M shares, $493.33M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API